Exact Mass: 500.13185539999995
Exact Mass Matches: 500.13185539999995
Found 315 metabolites which its exact mass value is equals to given mass value 500.13185539999995
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Nocardicin A
C23H24N4O9 (500.15432139999996)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
(S)-N-[3-(3,4-Methylenedioxyphenyl)-2-(acetylthio)methyl-1-oxoprolyl]-(S)-alanine benzyl ester
C25H28N2O7S (500.16171380000003)
Nocardicin B
C23H24N4O9 (500.15432139999996)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
Orcein
Once used as a food colouring but now banned throughout the EC Cudbear is a dye extracted from orchil lichens that produces colours in the purple range. It can be used to dye wool and silk, without the use of mordant. Cudbear was the first dye to be invented in modern times, and one of the few dyes to be credited to a named individual. Orcinol is extracted from archil lichen, Rocella tinctoria. It is then converted to orcein by ammonia and air. Orcein is a reddish-brown dye, orchil is a purple-blue dye. Orcein is also used as a stain in microscopy to visualize elastic fibers,Hepatitis B surface antigens and copper associated proteins. It is a mixture of phenoxazone derivates - hydroxyorceins, aminoorceins, and aminoorceinimines.
Lyoniresinol 9'-sulfate
C22H28O11S (500.13522580000006)
Lyoniresinol 9-sulfate is found in green vegetables. Lyoniresinol 9-sulfate is a constituent of the roots of Polygonum cuspidatum (Japanese knotweed).
S)-2-(5(((1,2-Dihydro-3-methyl-1-oxobenzo(F)quinazolin-9-YL)methyl)amino)1-oxo-2-isoindolinyl)glutaric acid
Baohuoside II
C26H28O10 (500.16823880000004)
(E)-N-(2-(((3-(4-Chlorophenyl)allyl)(methyl)amino)methyl)phenyl)-N-(2-hydroxyethyl)-4-methoxybenzenesulfonamide
C26H29ClN2O4S (500.15364640000007)
Nocardicin A
C23H24N4O9 (500.15432139999996)
Simotinib
C25H26ClFN4O4 (500.16265180000005)
Ikarisoside A
C26H28O10 (500.16823880000004)
Baohuoside II is a natural product found in Epimedium grandiflorum, Epimedium diphyllum, and other organisms with data available. IKarisoside A (Icarisoside-A) is a natural flavonol glycoside and has anti-inflammatory properties. IKarisoside A (Icarisoside-A) is a natural flavonol glycoside and has anti-inflammatory properties.
Puerarin 4,6-diacetate
C25H24O11 (500.13185539999995)
Apigenin 7-(6-crotonylglucoside)
C25H24O11 (500.13185539999995)
Epigallocatechin 5,3,5-trimethyl ether 3-O-gallate
C25H24O11 (500.13185539999995)
1,4,5-trihydroxynaphthalene 1,4-di-O-beta-D-glucopyranoside|5-hydroxynaphthalene-1,4-di-O-beta-D-glucopyranoside|juglanoside F
Penta-Ac-2,3,4,4,5-Pentahydroxyflavan
C25H24O11 (500.13185539999995)
3-(2,4-di-O-acetyl-alpha-L-rhamnopyranosyl)emodin
C25H24O11 (500.13185539999995)
(E)-2-(6-(bis(4-hydroxyphenyl)methylene)-5-(4-hydroxyphenyl)cyclohexa-2,4-dienylidene)-1-(4-hydroxyphenyl)ethanone|selaginellin G
3-(3,4-di-O-acetyl-alpha-L-rhamnopyranosyl)emodin
C25H24O11 (500.13185539999995)
(betaS,2R,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-3,5,7-trihydroxy-beta-(2,4,5-trihydroxyphenyl)-2H-1-benzopyran-6-propanoic acid methyl ester|6-[(1S)-3-methoxy-3-oxo-1-(2,4,5-trihydroxyphenyl)propyl]catechin
C25H24O11 (500.13185539999995)
5-[(1E)-2-(4beta-D-glucopyranosyloxyphenyl)ethenyl]-4,7-dimethoxy-3-methyl-2H-1-benzopyran-2-one
C26H28O10 (500.16823880000004)
Guibourtinidol-(4alpha->2)-3,5,3,4-tetrahydroxystilbene
(+)-gallocatechin-8-S-beta-D-glucopyranoside|excoecariphenol B
(6-trans-p-coumaroyl)-3-O-beta-D-glucopyranosyl-(5-acetyl)-2-deoxy-D-ribonic acid
6-(beta-D-glucopyranosyl)oxy-7-hydroxy-3-[(2-oxo-2H-1-benzopyran-7-yl)oxy]-2H-1-benzopyran-2-one|daphneretusin A
C24H20O12 (500.09547200000003)
6,7-dihydroxy-3-methoxy-8-[2-oxo-2H-1-benzopyran-7-(O-beta-D-glucopyranosyl)-8-yl]-2H-1-benzopyran-2-one
C24H20O12 (500.09547200000003)
3-O-p-coumaroyl-5-O-caffeoylquinic acid|3-p-(E)-coumaroyl-5-(E)-caffeoylquinic acid
C25H24O11 (500.13185539999995)
1-O-trans-caffeoyl-5-O-trans-p-coumaroylquinic acid
C25H24O11 (500.13185539999995)
2,4,6-trihydroxybenzoic acid-4-O-2,3,4,6-tetraacetylglucoside
1,4,5-trihydroxynaphthalene 1,5-di-O-beta-D-glucopyranoside|juglanoside G
Penta-Ac-(-)-3,4,4,5,7-Pentahydroxyflavan
C25H24O11 (500.13185539999995)
7-O-[beta-D-glucopyranosyl]-6-hydroxy-3-(2-oxo-2H-1-benzopyran-7-yl)-2H-1-benzopyran-2-one
C24H20O12 (500.09547200000003)
(2R,3R)-7,4-dihydroxy-5,3,5-trimethoxyflavan-3-O-gallate
C25H24O11 (500.13185539999995)
5-Carboxypyranopelargonidin 3-O-beta-glucopyranoside
C24H20O12 (500.09547200000003)
Haploperoside C
relative retention time with respect to 9-anthracene Carboxylic Acid is 0.543 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.542
6-methoxy-7-[3,4,5-trihydroxy-6-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxymethyl]oxan-2-yl]oxychromen-2-one
6-hydroxy-8-(7-hydroxy-2-oxochromen-8-yl)-7-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one
C24H20O12 (500.09547200000003)
C22H28O13_3-[6-({6-O-[(2R,3R,4R)-3,4-Dihydroxy-4-(hydroxymethyl)tetrahydro-2-furanyl]-beta-D-glucopyranosyl}oxy)-1-benzofuran-5-yl]propanoic acid
6-methoxy-7-[3,4,5-trihydroxy-6-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxymethyl]oxan-2-yl]oxychromen-2-one
6-hydroxy-8-(7-hydroxy-2-oxochromen-8-yl)-7-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one [IIN-based on: CCMSLIB00000846875]
C24H20O12 (500.09547200000003)
6-hydroxy-8-(7-hydroxy-2-oxochromen-8-yl)-7-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one [IIN-based: Match]
C24H20O12 (500.09547200000003)
Cys Cys Glu Phe
Cys Cys Phe Glu
Cys Cys Ile Tyr
C21H32N4O6S2 (500.17631719999997)
Cys Cys Leu Tyr
C21H32N4O6S2 (500.17631719999997)
Cys Cys Tyr Ile
C21H32N4O6S2 (500.17631719999997)
Cys Cys Tyr Leu
C21H32N4O6S2 (500.17631719999997)
Cys Asp Thr Tyr
C20H28N4O9S (500.15769180000007)
Cys Asp Tyr Thr
C20H28N4O9S (500.15769180000007)
Cys Glu Cys Phe
Cys Glu Phe Cys
Cys Glu Ser Tyr
C20H28N4O9S (500.15769180000007)
Cys Glu Tyr Ser
C20H28N4O9S (500.15769180000007)
Cys Phe Cys Glu
Cys Phe Glu Cys
Cys Phe Met Thr
C21H32N4O6S2 (500.17631719999997)
Cys Phe Thr Met
C21H32N4O6S2 (500.17631719999997)
Cys His Asn Gln
Cys His Gln Asn
Cys Ile Cys Tyr
C21H32N4O6S2 (500.17631719999997)
Cys Ile Tyr Cys
C21H32N4O6S2 (500.17631719999997)
Cys Leu Cys Tyr
C21H32N4O6S2 (500.17631719999997)
Cys Leu Tyr Cys
C21H32N4O6S2 (500.17631719999997)
Cys Met Phe Thr
C21H32N4O6S2 (500.17631719999997)
Cys Met Thr Phe
C21H32N4O6S2 (500.17631719999997)
Cys Asn His Gln
Cys Asn Gln His
Cys Gln His Asn
Cys Gln Asn His
Cys Ser Glu Tyr
C20H28N4O9S (500.15769180000007)
Cys Ser Tyr Glu
C20H28N4O9S (500.15769180000007)
Cys Thr Asp Tyr
C20H28N4O9S (500.15769180000007)
Cys Thr Phe Met
C21H32N4O6S2 (500.17631719999997)
Cys Thr Met Phe
C21H32N4O6S2 (500.17631719999997)
Cys Thr Tyr Asp
C20H28N4O9S (500.15769180000007)
Cys Tyr Cys Ile
C21H32N4O6S2 (500.17631719999997)
Cys Tyr Cys Leu
C21H32N4O6S2 (500.17631719999997)
Cys Tyr Asp Thr
C20H28N4O9S (500.15769180000007)
Cys Tyr Glu Ser
C20H28N4O9S (500.15769180000007)
Cys Tyr Ile Cys
C21H32N4O6S2 (500.17631719999997)
Cys Tyr Leu Cys
C21H32N4O6S2 (500.17631719999997)
Cys Tyr Ser Glu
C20H28N4O9S (500.15769180000007)
Cys Tyr Thr Asp
C20H28N4O9S (500.15769180000007)
Asp Cys Thr Tyr
C20H28N4O9S (500.15769180000007)
Asp Cys Tyr Thr
C20H28N4O9S (500.15769180000007)
Asp Asp Asp His
Asp Asp His Asp
Asp His Asp Asp
Asp Thr Cys Tyr
C20H28N4O9S (500.15769180000007)
Asp Thr Tyr Cys
C20H28N4O9S (500.15769180000007)
Asp Tyr Cys Thr
C20H28N4O9S (500.15769180000007)
Asp Tyr Thr Cys
C20H28N4O9S (500.15769180000007)
Glu Cys Cys Phe
Glu Cys Phe Cys
Glu Cys Ser Tyr
C20H28N4O9S (500.15769180000007)
Glu Cys Tyr Ser
C20H28N4O9S (500.15769180000007)
Glu Phe Cys Cys
Glu Ser Cys Tyr
C20H28N4O9S (500.15769180000007)
Glu Ser Tyr Cys
C20H28N4O9S (500.15769180000007)
Glu Tyr Cys Ser
C20H28N4O9S (500.15769180000007)
Glu Tyr Ser Cys
C20H28N4O9S (500.15769180000007)
Phe Cys Cys Glu
Phe Cys Glu Cys
Phe Cys Met Thr
C21H32N4O6S2 (500.17631719999997)
Phe Cys Thr Met
C21H32N4O6S2 (500.17631719999997)
Phe Glu Cys Cys
Phe Met Cys Thr
C21H32N4O6S2 (500.17631719999997)
Phe Met Thr Cys
C21H32N4O6S2 (500.17631719999997)
Phe Thr Cys Met
C21H32N4O6S2 (500.17631719999997)
Phe Thr Met Cys
C21H32N4O6S2 (500.17631719999997)
Gly Met Met Tyr
C21H32N4O6S2 (500.17631719999997)
Gly Met Tyr Met
C21H32N4O6S2 (500.17631719999997)
Gly Tyr Met Met
C21H32N4O6S2 (500.17631719999997)
His Cys Asn Gln
His Cys Gln Asn
His Asp Asp Asp
His Asn Cys Gln
His Asn Gln Cys
His Gln Cys Asn
His Gln Asn Cys
Ile Cys Cys Tyr
C21H32N4O6S2 (500.17631719999997)
Ile Cys Tyr Cys
C21H32N4O6S2 (500.17631719999997)
Ile Tyr Cys Cys
C21H32N4O6S2 (500.17631719999997)
Leu Cys Cys Tyr
C21H32N4O6S2 (500.17631719999997)
Leu Cys Tyr Cys
C21H32N4O6S2 (500.17631719999997)
Leu Tyr Cys Cys
C21H32N4O6S2 (500.17631719999997)
Met Cys Phe Thr
C21H32N4O6S2 (500.17631719999997)
Met Cys Thr Phe
C21H32N4O6S2 (500.17631719999997)
Met Phe Cys Thr
C21H32N4O6S2 (500.17631719999997)
Met Phe Thr Cys
C21H32N4O6S2 (500.17631719999997)
Met Gly Met Tyr
C21H32N4O6S2 (500.17631719999997)
Met Gly Tyr Met
C21H32N4O6S2 (500.17631719999997)
Met Met Gly Tyr
C21H32N4O6S2 (500.17631719999997)
Met Met Tyr Gly
C21H32N4O6S2 (500.17631719999997)
Met Thr Cys Phe
C21H32N4O6S2 (500.17631719999997)
Met Thr Phe Cys
C21H32N4O6S2 (500.17631719999997)
Met Tyr Gly Met
C21H32N4O6S2 (500.17631719999997)
Met Tyr Met Gly
C21H32N4O6S2 (500.17631719999997)
Asn Cys His Gln
Asn Cys Gln His
Asn His Cys Gln
Asn His Gln Cys
Asn Gln Cys His
Asn Gln His Cys
Gln Cys His Asn
Gln Cys Asn His
Gln His Cys Asn
Gln His Asn Cys
Gln Asn Cys His
Gln Asn His Cys
Ser Cys Glu Tyr
C20H28N4O9S (500.15769180000007)
Ser Cys Tyr Glu
C20H28N4O9S (500.15769180000007)
Ser Glu Cys Tyr
C20H28N4O9S (500.15769180000007)
Ser Glu Tyr Cys
C20H28N4O9S (500.15769180000007)
Ser Tyr Cys Glu
C20H28N4O9S (500.15769180000007)
Ser Tyr Glu Cys
C20H28N4O9S (500.15769180000007)
Thr Cys Asp Tyr
C20H28N4O9S (500.15769180000007)
Thr Cys Phe Met
C21H32N4O6S2 (500.17631719999997)
Thr Cys Met Phe
C21H32N4O6S2 (500.17631719999997)
Thr Cys Tyr Asp
C20H28N4O9S (500.15769180000007)
Thr Asp Cys Tyr
C20H28N4O9S (500.15769180000007)
Thr Asp Tyr Cys
C20H28N4O9S (500.15769180000007)
Thr Phe Cys Met
C21H32N4O6S2 (500.17631719999997)
Thr Phe Met Cys
C21H32N4O6S2 (500.17631719999997)
Thr Met Cys Phe
C21H32N4O6S2 (500.17631719999997)
Thr Met Phe Cys
C21H32N4O6S2 (500.17631719999997)
Thr Tyr Cys Asp
C20H28N4O9S (500.15769180000007)
Thr Tyr Asp Cys
C20H28N4O9S (500.15769180000007)
Tyr Cys Cys Ile
C21H32N4O6S2 (500.17631719999997)
Tyr Cys Cys Leu
C21H32N4O6S2 (500.17631719999997)
Tyr Cys Asp Thr
C20H28N4O9S (500.15769180000007)
Tyr Cys Glu Ser
C20H28N4O9S (500.15769180000007)
Tyr Cys Ile Cys
C21H32N4O6S2 (500.17631719999997)
Tyr Cys Leu Cys
C21H32N4O6S2 (500.17631719999997)
Tyr Cys Ser Glu
C20H28N4O9S (500.15769180000007)
Tyr Cys Thr Asp
C20H28N4O9S (500.15769180000007)
Tyr Asp Cys Thr
C20H28N4O9S (500.15769180000007)
Tyr Asp Thr Cys
C20H28N4O9S (500.15769180000007)
Tyr Glu Cys Ser
C20H28N4O9S (500.15769180000007)
Tyr Glu Ser Cys
C20H28N4O9S (500.15769180000007)
Tyr Gly Met Met
C21H32N4O6S2 (500.17631719999997)
Tyr Ile Cys Cys
C21H32N4O6S2 (500.17631719999997)
Tyr Leu Cys Cys
C21H32N4O6S2 (500.17631719999997)
Tyr Met Gly Met
C21H32N4O6S2 (500.17631719999997)
Tyr Met Met Gly
C21H32N4O6S2 (500.17631719999997)
Tyr Ser Cys Glu
C20H28N4O9S (500.15769180000007)
Tyr Ser Glu Cys
C20H28N4O9S (500.15769180000007)
Tyr Thr Cys Asp
C20H28N4O9S (500.15769180000007)
Tyr Thr Asp Cys
C20H28N4O9S (500.15769180000007)
EUK 118
C22H25MnN2O8 (500.09912899999995)
KN-93
C26H29ClN2O4S (500.15364640000007)
D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors
Orcein
D004396 - Coloring Agents
Lyoniresinol 9'-sulfate
C22H28O11S (500.13522580000006)
1,4-PHENYLENEBIS[[4-(4-AMINOPHENOXY)PHENYL]METHANONE]
ICI 204,448 hydrochloride
C23H27Cl3N2O4 (500.10363120000005)
ICI-204448 is a κ-opioid agonist with limited access to the CNS, ICI-204448 can displace the binding of the kappa-opioid ligand 3H-bremazocine from guinea pig cerebellum membranes[1].
[4,5,8-triacetyloxy-6-(1-acetyloxy-4-methylpent-3-enyl)naphthalen-1-yl] acetate
C26H28O10 (500.16823880000004)
Pitavastatin calcium
C25H23FNO4.1/2 Ca (500.08628500000003)
Pitavastatin Calcium (NK-104 hemicalcium) is a potent hydroxymethylglutaryl-CoA (HMG-CoA) reductase inhibitor. Pitavastatin Calcium (NK-104 hemicalcium) inhibits cholesterol synthesis from acetic acid with an IC50 of 5.8 nM in HepG2 cells. Pitavastatin Calcium is an efficient hepatocyte low-density lipoprotein-cholesterol (LDL-C) receptor inducer. Pitavastatin Calcium also possesses anti-atherosclerotic, anti-asthmatic, anti-osteoarthritis, antineoplastic, neuroprotective, hepatoprotective and reno-protective effects[1][2][3][8].
4-hexyl-2-(4-hexyl-5-thiophen-2-yl-1,3-thiazol-2-yl)-5-thiophen-2-yl-1,3-thiazole
C26H32N2S4 (500.14482319999996)
Regorafenib Monohydrate
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor Regorafenib (BAY 73-4506) monohydrate is an orally active and potent multi-targeted receptor tyrosine kinase inhibitor, with IC50 values of 13/4.2/46, 22, 7, 1.5 and 2.5 nM for VEGFR1/2/3, PDGFRβ, Kit, RET and Raf-1, respectively. Regorafenib monohydrate shows very robust antitumor and antiangiogenic activity[1].
6-Hydroxy Warfarin β-D-Glucuronide
C25H24O11 (500.13185539999995)
Uredofos
C19H25N4O6PS2 (500.09530800000005)
C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent
5-(4-CHLOROPHENYL)-1-(2,4-DICHLOROPHENYL)-4-METHYLPYRAZOLE-3-CARBOXYLICACID
C27H34BrO2P (500.14796540000003)
(6R,7R)-3-Hydroxy-8-oxo-7-[(phenylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid diphenyl methyl ester
Benzoic acid, 4-(((2,3-dihydro-6-((2-methylpropyl)(2-thiazolylsulfonyl)amino)-1H-inden-5-yl)oxy)methyl)-3-methyl-
5-hydroxy-2-methylchromone-7-O-rutinoside
A disaccharide derivative that consists of 5-hydroxy-2-methylchromone substituted by a rutinosyl group at position 7 via a glycosidic linkage. Isolated from Crossosoma bigelovii, it exhibits antineoplastic activity.
1843U89;(2S)-2-(5-{[(3-Methyl-1-oxo-1,2-dihydrobenzo[f]quinazolin-9-yl)me thyl]amino}-1-oxo-1,3-dihydro-2H-isoindol-2-yl)pentanedioic acid
S)-2-(5(((1,2-Dihydro-3-methyl-1-oxobenzo(F)quinazolin-9-YL)methyl)amino)1-oxo-2-isoindolinyl)glutaric acid
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite C471 - Enzyme Inhibitor > C2021 - Thymidylate Synthase Inhibitor D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists D000970 - Antineoplastic Agents
2-glutathion-S-yl-3-(4-nitrophenyl) propionic acid
(2S)-2-amino-4-[4-[(E)-C-[[(3S)-1-[(R)-carboxy-(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]carbamoyl]-N-hydroxycarbonimidoyl]phenoxy]butanoic acid
C23H24N4O9 (500.15432139999996)
(3S,alphaR)-3-[[[4-[(R)-3-Amino-3-carboxypropoxy]phenyl]-[(Z)-hydroxyimino]acetyl]amino]-alpha-(4-hydroxyphenyl)-2-oxo-1-azetidineacetic acid
C23H24N4O9 (500.15432139999996)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
7-(4-hydroxyphenyl)-11-oxo-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,8-dioxatricyclo[7.3.1.05,13]trideca-1(12),3,5(13),6,9-pentaene-3-carboxylic acid
C24H20O12 (500.09547200000003)
[4-[(2-Chlorophenyl)methylsulfonyl]-3-nitrophenyl]-[4-(2-pyridinyl)-1-piperazinyl]methanone
C23H21ClN4O5S (500.09211260000006)
2-[cyclopentyl-[1-oxo-2-(5-thiophen-2-yl-2-tetrazolyl)ethyl]amino]-N-(2-oxolanylmethyl)-2-thiophen-2-ylacetamide
2-[4-(4-methoxyphenyl)-4-methyl-2,5-dioxo-1-imidazolidinyl]-N-[4-(6-methyl-1,3-benzothiazol-2-yl)phenyl]acetamide
2-(4-morpholinyl)-9-(3-thiophenyl)-N-[[6-(trifluoromethyl)-1H-benzimidazol-2-yl]methyl]-6-purinamine
C22H19F3N8OS (500.13545600000003)
2-[(1R,3R,4aS,9aR)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(2,2,2-trifluoroethyl)acetamide
C22H23F3N2O6S (500.12288540000003)
N-[(2R,3R)-4-[(4-chlorophenyl)sulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-2-fluoro-N-methylbenzamide
C23H30ClFN2O5S (500.15478920000004)
2-[(1S,3S,4aS,9aR)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2,2,2-trifluoroethyl)acetamide
C22H23F3N2O6S (500.12288540000003)
2-[(1S,3S,4aR,9aS)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(2,2,2-trifluoroethyl)acetamide
C22H23F3N2O6S (500.12288540000003)
N-[(2R,3S)-4-[(4-chlorophenyl)sulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-2-fluoro-N-methylbenzamide
C23H30ClFN2O5S (500.15478920000004)
N-[[(4R,5R)-8-(4-fluorophenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide
N-[[(4R,5R)-8-(4-fluorophenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide
N-[[(4S,5R)-8-(4-fluorophenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide
N-[[(4R,5S)-8-(4-fluorophenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide
2-[(1R,3R,4aR,9aS)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2,2,2-trifluoroethyl)acetamide
C22H23F3N2O6S (500.12288540000003)
N-[(2S,3R)-4-[(4-chlorophenyl)sulfonyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-2-fluoro-N-methylbenzamide
C23H30ClFN2O5S (500.15478920000004)
N-[(2R,3S)-4-[(4-chlorophenyl)sulfonyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-2-fluoro-N-methylbenzamide
C23H30ClFN2O5S (500.15478920000004)
N-[[(4S,5S)-8-(4-fluorophenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide
N-[[(4S,5S)-8-(4-fluorophenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide
N-[[(4S,5R)-8-(4-fluorophenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide
N-[[(4R,5S)-8-(4-fluorophenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylmethanesulfonamide
2-[(1S,3R,4aS,9aR)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2,2,2-trifluoroethyl)acetamide
C22H23F3N2O6S (500.12288540000003)
N-[(2S,3S)-4-[(4-chlorophenyl)sulfonyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-2-fluoro-N-methylbenzamide
C23H30ClFN2O5S (500.15478920000004)
N-[(2S,3R)-4-[(4-chlorophenyl)sulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-2-fluoro-N-methylbenzamide
C23H30ClFN2O5S (500.15478920000004)
N-[(2S,3S)-4-[(4-chlorophenyl)sulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-2-fluoro-N-methylbenzamide
C23H30ClFN2O5S (500.15478920000004)
(beta-D-glucopyranosyloxymethyl)deoxyuridine 5-monophosphate
C16H25N2O14P (500.10433600000005)
A pyrimidine 2-deoxyribonucleoside 5-monophosphate having beta-D-glucopyranosyloxymethyluracil (base J) as the nucleobase
1,2-diacetyl-3-[beta-D-glucosyl-(1->6)-beta-D-galactosyl]-sn-glycerol
C19H32O15 (500.17411219999997)
(2S)-2-ammonio-4-{4-[(1Z)-2-({(3S)-1-[(R)-carboxy(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl}amino)-N-hydroxy-2-oxoethanimidoyl]phenoxy}butanoate
C23H24N4O9 (500.15432139999996)
(2S,3S,4S,5R)-6-[7-carbamoyl-5-hydroxy-1-(4-phenylbutan-2-yl)indol-6-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
6-({5-[3-(2H-1,3-benzodioxol-5-yl)-3-oxopropanoyl]-1-benzofuran-4-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid
C24H20O12 (500.09547200000003)
(2S,3S,4S,5R)-6-[7-carbamoyl-6-hydroxy-1-(4-phenylbutan-2-yl)indol-5-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
7-(4-hydroxyphenyl)-11-oxo-6-[(2S,4S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,8-dioxatricyclo[7.3.1.05,13]trideca-1(12),3,5(13),6,9-pentaene-3-carboxylic acid
C24H20O12 (500.09547200000003)
6-Hydroxy-8-(7-hydroxy-2-oxochromen-8-yl)-7-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one
C24H20O12 (500.09547200000003)
[2-Acetyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropyl] acetate
C19H32O15 (500.17411219999997)
Isonocardicin A
C23H24N4O9 (500.15432139999996)
A nocardicin in which the beta-lactam moiety is substituted at position 1 by a carboxy(4-hydroxyphenyl)methyl group and at position 3 by a [(2Z)-2-(hydroxyimino)-2-(4-hydroxyphenyl)acetyl]nitrilo group in which the phenolic hydroxy group is substituted by a (3S)-3-amino-3-carboxypropyl group.
isonocardicin A zwitterion
C23H24N4O9 (500.15432139999996)
An L-alpha-amino acid zwitterion resulting from the transfer of a proton from the carboxy group to the amino group of isonocardicin A.